Titan America SA (TTAM) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TTAM SEC filings page.
Titan America SA (TTAM) reported $1.7B in revenue for fiscal year 2025, up 1.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Modest sales growth is translating into stronger cash generation, lower leverage, and a much more liquid short-term balance sheet.
Revenue growth was modest across FY2023-FY2025, yet net profit margin widened from9.8% to11.1% , indicating more profit per sales dollar rather than volume doing the work. Operating cash flow rose from$227M to$295M while free cash flow margin reached8.1% , showing that the earnings improvement was supported by cash after reinvestment.
The balance sheet became materially less constrained: current ratio tripled to 3.0x while debt-to-equity fell to 0.1x, so FY2025 financing relied more on equity and current assets than on debt. This combination points to improved flexibility in meeting near-term obligations, not merely a larger asset base.
Capital intensity remains substantial: spending on property and equipment rose from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Titan America SA's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Titan America SA, and counted as zero in the overall score.
Titan America SA's revenue grew a modest 1.8% year-over-year to $1.7B. This slow but positive growth earns a score of 39/100.
Titan America SA carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.03, Titan America SA holds $3.03 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 79/100.
Titan America SA has a free cash flow margin of 8.1%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Titan America SA, and counted as zero in the overall score.
Titan America SA passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Titan America SA generates $1.59 in operating cash flow ($295.4M OCF vs $185.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Titan America SA held $211.8M in cash against $55.4M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
TTAM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
TTAM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2310-K |
|---|---|---|---|
| Total Assets | $1.9B+20.9% | $1.6B+4.5% | $1.5B |
| Current Assets | $610.0M+58.7% | $384.3M+3.0% | $372.9M |
| Cash & Equivalents | $211.8M+1646.5% | $12.1M-45.0% | $22.0M |
| Inventory | $226.4M-0.5% | $227.6M+19.8% | $190.0M |
| Goodwill | $221.6M0.0% | $221.6M0.0% | $221.6M |
| Total Liabilities | $859.8M+5.3% | $816.2M+4.8% | $779.0M |
| Current Liabilities | $201.2M-15.8% | $239.0M-51.4% | $492.0M |
| Non-Current Liabilities | $658.6M+14.1% | $577.2M+101.1% | $287.1M |
| Long-Term Debt | $55.4M-1.0% | $56.0M+4.1% | $53.7M |
| Total Equity | $1.0B+37.9% | $750.0M+4.2% | $719.8M |
| Retained Earnings | $777.7M+30.2% | $597.3M+15.2% | $518.6M |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.
TTAM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
TTAM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Titan America SA TTAM | FY2025 | $1.7B | $185.4M | 11.1% | $2.5B | 43/100 |
| Tecnoglass Holdings Inc. TGLS | FY2025 | $983.6M | $159.6M | 16.2% | $1.5B | 70/100 |
| United States Lime & Minerals USLM | FY2025 | $372.7M | $134.3M | 36.0% | $3.2B | 91/100 |
| Knife River Corporation KNF | FY2025 | $3.1B | $157.1M | 5.0% | $2.9B | 55/100 |
| Eagle Materials, Inc. EXP | FY2026 | $2.3B | $423.8M | 18.4% | $5.3B | 72/100 |
Where Titan America SA Ranks
Frequently Asked Questions
What is Titan America SA's annual revenue?
Titan America SA (TTAM) reported $1.7B in total revenue for fiscal year 2025. This represents a 1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Titan America SA's revenue growing?
Titan America SA (TTAM) revenue grew by 1.8% year-over-year, from $1.6B to $1.7B in fiscal year 2025.
Is Titan America SA profitable?
Yes, Titan America SA (TTAM) reported a net income of $185.4M in fiscal year 2025, with a net profit margin of 11.1%.
How much debt does Titan America SA have?
As of fiscal year 2025, Titan America SA (TTAM) had $211.8M in cash and equivalents against $55.4M in long-term debt.
What is Titan America SA's net profit margin?
Titan America SA (TTAM) had a net profit margin of 11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Titan America SA's return on equity (ROE)?
Titan America SA (TTAM) has a return on equity of 17.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Titan America SA's free cash flow?
Titan America SA (TTAM) generated $134.9M in free cash flow during fiscal year 2025. This represents a 19.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Titan America SA's operating cash flow?
Titan America SA (TTAM) generated $295.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Titan America SA's total assets?
Titan America SA (TTAM) had $1.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Titan America SA's capital expenditures?
Titan America SA (TTAM) invested $160.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Titan America SA's current ratio?
Titan America SA (TTAM) had a current ratio of 3.03 as of fiscal year 2025, which is generally considered healthy.
What is Titan America SA's debt-to-equity ratio?
Titan America SA (TTAM) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Titan America SA's return on assets (ROA)?
Titan America SA (TTAM) had a return on assets of 9.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Titan America SA's P/E ratio?
Titan America SA (TTAM) trades at 13.3x earnings, its market capitalization divided by net income of $185.4M net income, FY2025. The market capitalization is $2.5B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Titan America SA's price-to-sales ratio?
Titan America SA (TTAM) trades at 1.5x sales, its market capitalization divided by revenue of $1.7B revenue, FY2025. The market capitalization is $2.5B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Titan America SA's Piotroski F-Score?
Titan America SA (TTAM) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Titan America SA's earnings high quality?
Titan America SA (TTAM) has an earnings quality ratio of 1.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Titan America SA?
Titan America SA (TTAM) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.